Guangdong VTR Bio-Tech Co., Ltd.

Shenzhen Stock Exchange 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd. Revenue for the year ending December 31, 2023: USD 112.12 M

Guangdong VTR Bio-Tech Co., Ltd. Revenue is USD 112.12 M for the year ending December 31, 2023, a -34.10% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Guangdong VTR Bio-Tech Co., Ltd. Revenue for the year ending December 31, 2022 was USD 170.13 M, a -42.87% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Revenue for the year ending December 31, 2021 was USD 297.79 M, a 1.52% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Revenue for the year ending December 31, 2020 was USD 293.34 M, a -0.26% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Revenue for the year ending December 31, 2019 was USD 294.11 M, a 14.40% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
SV Wall Street
Shenzhen Stock Exchange: 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd.

CEO Mr. Derong Zhou
IPO Date Jan. 28, 2014
Location China
Headquarters No. 8 Pingbei Road 1
Employees 1,119
Sector Healthcare
Industries
Biotechnology Agriculture Biofuel Fertilizers Personal Care Pet Food Pharmaceuticals Plastics
Description

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email